| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/03/2008 | EP1997487A1 Product for use in the prevention and treatment of cardiovascular diseases, cancer and chronic inflammatory diseases |
| 12/03/2008 | EP1996701A1 Cytotoxicity mediation of cells evidencing surface expression of trop-2 |
| 12/03/2008 | EP1996700A1 Cancerous disease modifying antibody 141205-05 |
| 12/03/2008 | EP1996699A1 Cancerous disease modifying antibodies |
| 12/03/2008 | EP1996625A1 Anti-tat226 antibodies and immunoconjugates |
| 12/03/2008 | EP1996624A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and ovarian cancer |
| 12/03/2008 | EP1996623A1 Cancerous disease modifying antibodies for diagnostic and therapeutic use in breast and prostate cancer |
| 12/03/2008 | EP1996612A1 Compositions for treatment of cancer |
| 12/03/2008 | EP1996604A1 Steroidal compounds as steroid sulphatase inhibitors |
| 12/03/2008 | EP1996592A1 Indolopyridines as eg5 kinesin modulators |
| 12/03/2008 | EP1996591A1 Spiroindolinone derivatives |
| 12/03/2008 | EP1996590A1 Spiroindolinone derivatives |
| 12/03/2008 | EP1996588A1 Novel dual action receptors antagonists (dara) at the ati and eta receptors |
| 12/03/2008 | EP1996583A1 Thiazoles as nf-kb inhibitors (proteasome inhibitors) |
| 12/03/2008 | EP1996561A1 Bicyclic heterocycles, medicaments containing these compounds, their use and process for preparing them |
| 12/03/2008 | EP1996558A1 Heterobicyclic carboxamides as inhibitors for kinases |
| 12/03/2008 | EP1996553A2 Tumor necrosis factor alpha inhibitors and their use in the treatment of human diseases |
| 12/03/2008 | EP1996551A2 Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them. |
| 12/03/2008 | EP1996234A2 Nanoparticles for targeted delivery of active agents |
| 12/03/2008 | EP1996208A2 Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers |
| 12/03/2008 | EP1996202A1 Chemical compounds |
| 12/03/2008 | EP1996193A2 Combined treatment with an egfr kinase inhibitor and an agent that sensitizes tumor cells to the effects of egfr kinase inhibitors |
| 12/03/2008 | EP1996182A2 Cancer treatment with gamma-secretase inhibitors |
| 12/03/2008 | EP1737463B1 Pyrimidines with tie2 (tek) activity |
| 12/03/2008 | EP1641818B1 Polypeptides having binding affinity for her2 |
| 12/03/2008 | EP1560573B1 Use of n,n-dicylcohexyl-2-hydroxy-7,7-dimethylbicyclo[2.2.1]hept-1-ylmethanesulfonamide family members in therapy |
| 12/03/2008 | EP1513516B1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES |
| 12/03/2008 | EP1470144B1 Oligonucleotides comprising alternating segments and uses thereof |
| 12/03/2008 | EP1423105B1 Combinations of dmxaa and other anti-cancer agents |
| 12/03/2008 | EP1389101B1 Toluene sulfonamide-containing anti-tumor composition and method of use thereof |
| 12/03/2008 | EP1377540B1 Inhibitors of integrin alpha-v-beta-6 |
| 12/03/2008 | EP1313462B1 Use of asiatic acid or asiaticoside for treatment of cancer |
| 12/03/2008 | EP1303293B1 Sequential administration of cpt-11 and apo-2l polypeptide |
| 12/03/2008 | EP1187632B1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 12/03/2008 | EP0812208B1 Pharmaceutical compositions for controlled release of soluble receptors |
| 12/03/2008 | EP0606217B2 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 12/03/2008 | CN101316853A Oxazolopyridine derivatives as SIRTUIN modulators |
| 12/03/2008 | CN101316848A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 12/03/2008 | CN101316847A Pyrazolo(1, 5A) pyrimidines as protein kinase inhibitors |
| 12/03/2008 | CN101316845A Fused bicyclic mTOR inhibitors |
| 12/03/2008 | CN101316834A 1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent PARP inhibitors |
| 12/03/2008 | CN101316603A Processes for obtaining lignan extracts and compositions containing the lignan extracts |
| 12/03/2008 | CN101316593A Formulations of quinolinones |
| 12/03/2008 | CN101316588A Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 12/03/2008 | CN101314794A Method for detecting oral squamous-cell carcinoma and method for suppressing the same |
| 12/03/2008 | CN101314793A Method for detecting ovarian cancer and method for suppresssing the same |
| 12/03/2008 | CN101314619A Tumour treatment vaccine CTP37CRM197 immunogen, preparation method and application thereof |
| 12/03/2008 | CN101314617A Novel snake venom polypeptide, preparation and application thereof |
| 12/03/2008 | CN101314600A Antineoplastic compound, medicament composition and use thereof |
| 12/03/2008 | CN101314584A HGF/c-Met signalling channel restrainer, preparation method and application thereof |
| 12/03/2008 | CN101314046A Cyclodextrin inclusion method for hair orchid native |
| 12/03/2008 | CN101314043A Podophyllinic acid lactone derivant and preparation method thereof |
| 12/03/2008 | CN101314042A Water-soluble 4í»-nor-epipodophyllotoxin derivant and preparation method thereof |
| 12/03/2008 | CN101314041A Medicine carrying system of polymer micelle and preparation method thereof |
| 12/03/2008 | CN101314035A Uses of biological polyoses microcapsule |
| 12/03/2008 | CN101314021A Chinese medicinal composition for dispelling wind and relieving paralysis |
| 12/03/2008 | CN101313996A Pill for treating cancer |
| 12/03/2008 | CN101313983A Compound garlic soft capsule |
| 12/03/2008 | CN101313952A Traditional Chinese herb medicine for treating cancer |
| 12/03/2008 | CN101313931A Application of Heichou extract in preparing antineoplastic medicament |
| 12/03/2008 | CN101313926A Transcription regulating and controlling article composition |
| 12/03/2008 | CN101313901A Medicine uses of herpetone |
| 12/03/2008 | CN101313764A Fig fruit juice and preparation method thereof |
| 12/03/2008 | CN101313763A Fig oral liquid and preparation method thereof |
| 12/03/2008 | CN101313748A Fig soft capsule and production process |
| 12/03/2008 | CN101313747A Multipotential nutrition dietary cure health care ganodermataceae wheat sauce |
| 12/03/2008 | CN100439498C Small interference RNA of sinalbin myroxin receptor mIL17RE gene its coding gene and application thereof |
| 12/03/2008 | CN100439401C Carboxy methyl schizophllan polysacharide preparing method and its use for use in cosmetics and anticancer drugs |
| 12/03/2008 | CN100439400C Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 12/03/2008 | CN100439399C Human antibodies that bind human IL-12 and methods for producing |
| 12/03/2008 | CN100439395C Compositions and methods for therapy and diagnosis of ovarian cancer |
| 12/03/2008 | CN100439387C Novel cytosine monophosphate medicine precursor |
| 12/03/2008 | CN100439374C Epothilone derivatives |
| 12/03/2008 | CN100439366C Pyrido[2,3-d]pyrimidine-2,4-diamines as PDE2 inhibitors |
| 12/03/2008 | CN100439360C Crystals including a malic acid salt of a 3-pyrrole substituted 2-indolinone, and compositions thereof |
| 12/03/2008 | CN100439344C 4-anilino quinazoline derivatives as antiproliferative agents |
| 12/03/2008 | CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors |
| 12/03/2008 | CN100438920C Cancer gene therapeutic drug |
| 12/03/2008 | CN100438915C Targeted nanometer medicine carrier and its prepn. method |
| 12/03/2008 | CN100438913C Anti-cancer medicine composition |
| 12/03/2008 | CN100438910C Preventives/remedies for liver diseases |
| 12/03/2008 | CN100438909C 化合物 Compound |
| 12/03/2008 | CN100438908C CpG formulations and related methods |
| 12/03/2008 | CN100438882C Health care oral liquid of phellinus igniarius and its preparing method |
| 12/03/2008 | CN100438881C Application of crocodile blood in process for preparing anticancer antivirus and immunity improving medicine and health caring food |
| 12/03/2008 | CN100438877C (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses |
| 12/03/2008 | CN100438870C Method for treating diseases with omega interferon |
| 12/03/2008 | CN100438860C (f)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 12/03/2008 | CN100438855C Vinorelbine Bitartrate lipsome freeze-drying powder injection and its preparation method |
| 12/02/2008 | US7459562 Monocyclic heterocycles as kinase inhibitors |
| 12/02/2008 | US7459540 Fibroblast growth factor-like polypeptides |
| 12/02/2008 | US7459538 Recombinant tumor specific antibody and use thereof |
| 12/02/2008 | US7459536 HGF-SF monoclonal antibody combinations |
| 12/02/2008 | US7459528 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors |
| 12/02/2008 | US7459482 Agent for treatment of cisplatin-resistant cancer |
| 12/02/2008 | US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver |
| 12/02/2008 | US7459466 Antiinflammatory agents; autoimmune diseases; anticancer agents |
| 12/02/2008 | US7459464 Triple monoamine reuptake inhibitors for the treatment of chronic pain |
| 12/02/2008 | US7459462 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers |
| 12/02/2008 | US7459455 Pyrimidine compounds |